Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-29 · accession 0001773751-23-000189 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-03 | 2023-06-29 | HIMS | Boughton Soleil | CLO | M - OptEx | $2.43 | +85.7K | 253.8K | +51% | +$208.3K |
| D | 2023-07-03 | 2023-06-29 | HIMS | Boughton Soleil | CLO | S - Sale+OE | $9.01 | -85.7K | 168.1K | -34% | -$772.4K |
| D | 2023-07-03 | 2023-06-29 | HIMS | Boughton Soleil | CLO | M - OptEx | $0.00 | -85.7K | 227.4K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-29 | M | A | 85,729 | $2.43 | 253,818 | D | — | — | (F1) The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2023 by the Reporting Person. |
| 2 | Common | Class A Common Stock | 2023-06-29 | S | D | 85,729 | $9.01 | 168,089 | D | — | — | (F1) The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2023 by the Reporting Person. (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.003. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (right to buy) | 2023-06-29 | M | D | 85,729 | $0.00 | 227,390 | D | $2.43 · — to 2030-05-12 | 85,729 Class A Common Stock | (F3) The option award is subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48 of the shares subject to the option award vesting monthly beginning February 12, 2020. |